(GLOBE NEWSWIRE) -- (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today highlighted positive ...

This study illustrates a valuable application of BID-seq to bacterial RNA, allowing transcriptome-wide mapping of pseudouridine modifications across various bacterial species. The evidence presented ...

Discover a study comparing besifovir with other antivirals for reducing liver cancer risk in chronic hepatitis B patients.

Bladder cancer (BLCA) is one of the most prevalent malignancies of the urinary system, prone to recurrence, metastasis, and ...

Poster details durability and efficacy of ateganosine (THIO) treatment in non-small cell lung cancer (NSCLC) CHICAGO, Sept. 05, 2025 (GLOBE ...

MAIA Biotechnology, Inc. (NYSE American: MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies ...

The dream is as old as the first fossil pulled from the earth: What if we could see them? What if we could hear the ...

The modified nucleotide 6-thio-2’-deoxyguanosine induces telomerase-dependent telomeric DNA modification ... profound and persistent tumor regression in advanced, in vivo cancer models by induction of ...

Studying the genetics and neural mechanisms behind sneezing induced by bright light can help scientists better understand ...

In human cells, there are about 20,000 genes on a two-meter DNA strand—finely coiled up in a nucleus about 10 micrometers in ...

PARIS--(BUSINESS WIRE)--On August 24, 2025, the 23rd International Congress of Nutrition (ICN) convened in Paris, France, under the theme "Sustainable Food for Global Health." As the premier platform ...